Valuation: Acutus Medical, Inc.

Capitalization 5.98K 5.15K 4.71K 4.49K 8.23K 574K 8.37K 56.47K 21.85K 272K 22.45K 21.97K 949K P/E ratio 2023
-0.07x
P/E ratio 2024 -0.17x
Enterprise value 21.75M 18.72M 17.11M 16.33M 29.93M 2.09B 30.43M 205M 79.45M 991M 81.63M 79.88M 3.45B EV / Sales 2023
3.07x
EV / Sales 2024 1.16x
Free-Float
88.15%
Yield 2023 *
-
Yield 2024 -
1 day-66.67%
1 week-66.67%
Current month-90.00%
1 month-50.00%
3 months-50.00%
6 months-80.00%
Current year-50.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0.01
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.99
5 years 0
Extreme 0
18
10 years 0
Extreme 0
38.99
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 31/12/2010
Chief Operating Officer 64 30/09/2019
Corporate Secretary - 31/03/2025
Director TitleAgeSince
Director/Board Member 50 29/02/2016
Director/Board Member 70 16/03/2021
Director/Board Member 59 09/08/2021
Change 5d. change 1-year change 3-years change Capi.($)
-66.67%-66.67%-99.68%-99.99% 2.99K
+0.41%+7.46%-21.78%+6.17% 117B
+0.72%+1.74%+2.82%-13.43% 12.71B
+1.31%+7.86%+57.18%+140.38% 8.35B
-2.72%-3.76%-35.35%-68.95% 5.19B
-0.22%-3.48%+6.28%+24.13% 2.44B
-2.16%-5.10%-15.06%-15.06% 1.95B
-0.31%+1.96%+21.46%-8.96% 1.85B
-7.01%-8.41%-32.02%-57.58% 1.5B
Average -8.52%-0.50%-12.90%-10.37% 16.79B
Weighted average by Cap. +0.25%+6.01%-14.85%+8.55%

Financials

2023 2024
Net sales 7.16M 6.16M 5.64M 5.38M 9.86M 687M 10.02M 67.62M 26.17M 326M 26.89M 26.31M 1.14B 20.16M 17.35M 15.86M 15.13M 27.74M 1.93B 28.2M 190M 73.63M 918M 75.65M 74.02M 3.2B
Net income -81.66M -70.27M -64.25M -61.3M -112M -7.83B -114M -771M -298M -3.72B -306M -300M -12.96B -9.55M -8.22M -7.51M -7.17M -13.14M -916M -13.36M -90.12M -34.87M -435M -35.83M -35.06M -1.51B
Net Debt 16.08M 13.83M 12.65M 12.07M 22.12M 1.54B 22.49M 152M 58.72M 732M 60.33M 59.04M 2.55B 21.74M 18.71M 17.11M 16.32M 29.92M 2.09B 30.42M 205M 79.43M 990M 81.6M 79.86M 3.45B
Logo Acutus Medical, Inc.
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.
Employees
85
Date Price Change Volume
13/05/26 0.000100 $ -66.67% 1,361
12/05/26 0.000300 $ 0.00% 9,902
11/05/26 0.000300 $ 0.00% 625
08/05/26 0.000300 $ 0.00% 9,383